Table 1.
The percentage of ovarian cancer tumors in TCGA are shown with a cut-off of log2 tumor/normal ratio in more than 40 % tumors detected by Agilent G4502A microarray chips
| Gene | Log2 > 0.5 | Gene | Log2 < −0.5 |
|---|---|---|---|
| ALPK2 | 54 % | CSNK1G2 | 63 % |
| AURKA | 97 % | DDR2 | 80 % |
| BUB1B | 96 % | GUCY2F | 97 % |
| CDC7 | 89 % | ITK | 50 % |
| EPHB1 | 67 % | LRRK2 | 92 % |
| GRK6 | 44 % | MGC42105 | 46 % |
| KSR2 | 41 % | MKNK2 | 46 % |
| MAP3K7 | 45 % | PDGFRB | 49 % |
| NEK2 | 97 % | PRKCB | 61 % |
| NLK | 59 % | RET | 41 % |
| PIK3AP1 | 58 % | TEK | 91 % |
| PLK1 | 58 % | ||
| RRM1 | 41 % | ||
| TLK1 | 42 % |
The data shown are from the dataset of Nature publication [2]. The data were extracted from TCGA analysis with RMA normalized log2 ratio of tumor to nine normal controls